Recursion (RXRX) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.25
- EPS estimate
- −$0.24
- EPS surprise
- −4.17%
- Revenue surprise
- −33.42%
- Revenue
- $7.3M
- Revenue estimate
- $11.0M
- Reported
- Aug 5, 2026
Recursion reported Q2 2026 results on August 5, 2026, with a loss of $0.25 per share. That was 4.17% wider than the estimated $0.24 loss. Revenue of $7.3 million fell short of the $11.0 million consensus. Compared with Q2 2025, the loss narrowed from $0.41 per share, but revenue was about 62% lower than the $19.1 million of a year earlier.
Recursion lost money in all 20 quarters in the table. Annual losses were $1.37 per share in 2022, $1.57 in 2023, $1.66 in 2024 and $1.48 in 2025. Revenue is small and uneven from quarter to quarter. It rose to $74.3 million in 2025, about 27% more than in 2024, with Q4 2025 alone contributing $35.4 million, the quarterly high in the table. The last three quarterly losses, between $0.21 and $0.25 per share, are the narrowest in the table. Against EPS estimates the record is mixed, with 8 beats, 11 misses and one match.
Recursion reported third-quarter results between November 5 and November 10 in each of the past five years, pointing to early November 2026 for the next report. It will show whether the narrower losses of recent quarters hold.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | −$0.24 | −$0.25 | −4.17% | $7.3M | SEC |
| Q1 2026 | May 6, 2026 | −$0.27 | −$0.22 | +16.98% | $6.3M | SEC |
| Q4 2025 | Feb 25, 2026 | −$0.29 | −$0.21 | +27.59% | $35.4M | SEC |
| Q3 2025 | Nov 5, 2025 | −$0.38 | −$0.36 | +4.53% | $5.0M | SEC |
| Q2 2025 | Aug 5, 2025 | −$0.35 | −$0.41 | −16.05% | $19.1M | SEC |
| Q1 2025 | May 5, 2025 | −$0.52 | −$0.50 | +3.10% | $14.8M | SEC |
| Q4 2024 | Feb 28, 2025 | −$0.41 | −$0.53 | −28.83% | $4.5M | SEC |
| Q3 2024 | Nov 6, 2024 | −$0.33 | −$0.34 | −2.16% | $26.1M | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.38 | −$0.40 | −4.09% | $14.4M | SEC |
| Q1 2024 | May 9, 2024 | −$0.42 | −$0.39 | +7.87% | $13.5M | SEC |
| Q4 2023 | Feb 27, 2024 | −$0.45 | −$0.42 | +6.42% | $10.6M | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.39 | −$0.43 | −11.57% | $10.1M | SEC |
| Q2 2023 | Aug 8, 2023 | −$0.38 | −$0.38 | −1.33% | $11.0M | SEC |
| Q1 2023 | May 8, 2023 | −$0.35 | −$0.34 | +2.47% | $12.1M | SEC |
| Q4 2022 | Feb 27, 2023 | −$0.29 | −$0.31 | −6.90% | $13.7M | SEC |
| Q3 2022 | Nov 8, 2022 | −$0.38 | −$0.35 | +7.58% | $13.1M | SEC |
| Q2 2022 | Aug 9, 2022 | −$0.37 | −$0.38 | −1.79% | $7.7M | SEC |
| Q1 2022 | May 10, 2022 | $0.10 | −$0.33 | −430.00% | $5.3M | SEC |
| Q4 2021 | Mar 23, 2022 | −$0.31 | −$0.38 | −23.90% | $2.5M | SEC |
| Q3 2021 | Nov 10, 2021 | −$0.28 | −$0.28 | +0.00% | $2.5M | SEC |
Quarterly revenue
Frequently asked questions
When did Recursion (RXRX) last report earnings?
Recursion last reported on Aug 5, 2026, covering fiscal Q2 2026.
Did RXRX beat earnings estimates?
No. Recursion reported EPS of −$0.25 for Q2 2026 against a −$0.24 estimate — a 4.17% miss.
How much revenue did RXRX report last quarter?
Recursion reported $7.3M in revenue for Q2 2026, against a consensus estimate of $11.0M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.